Ceftriaxone and Atrioventricular block complete - a phase IV clinical study of FDA data

Summary:

Atrioventricular block complete is found among people who take Ceftriaxone, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ceftriaxone and have Atrioventricular block complete. It is created by eHealthMe based on reports of 33,453 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

33,453 people reported to have side effects when taking Ceftriaxone.
Among them, 25 people (0.07%) have Atrioventricular block complete.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 33,567 Ceftriaxone users for its effectiveness, alternative drugs and more.

What is Atrioventricular block complete?

Atrioventricular block complete (heart block complete) is found to be associated with 1,387 drugs and 775 conditions by eHealthMe.

Number of Ceftriaxone and Atrioventricular block complete reports submitted per year:

Could Ceftriaxone cause Atrioventricular block complete?

Time on Ceftriaxone when people have Atrioventricular block complete *:

Gender of people who have Atrioventricular block complete when taking Ceftriaxone *:

female: 45.83 %
male: 54.17 %

Age of people who have Atrioventricular block complete when taking Ceftriaxone *:

Common drugs people take besides Ceftriaxone *:

Clindamycin Hydrochloride: 4 people, 16.00%
Pantoprazole: 4 people, 16.00%
Isuprel: 3 people, 12.00%
Mestinon: 3 people, 12.00%
Meropenem: 3 people, 12.00%
Vancomycin: 3 people, 12.00%
Gamma-Oh: 3 people, 12.00%
Solu-Medrol: 3 people, 12.00%
Furosemide: 2 people, 8.00%
Metronidazole: 2 people, 8.00%

Common side effects people have besides Atrioventricular block complete *:

Hypotension (abnormally low blood pressure): 5 people, 20.00%
Cardiac Arrest: 5 people, 20.00%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 12.00%
Myocarditis (inflammation of heart muscle myocardium): 3 people, 12.00%
Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 3 people, 12.00%
Septic Shock (shock due to blood infection): 3 people, 12.00%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 3 people, 12.00%
Respiratory Distress (difficulty in breathing): 3 people, 12.00%
Pneumonia: 3 people, 12.00%
Lung Disorder (lung disease): 3 people, 12.00%

Common conditions people have *:

Pneumonia: 5 people, 20.00%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 3 people, 12.00%
Iron Deficiency Anaemia: 3 people, 12.00%
Constipation: 3 people, 12.00%
Breathing Difficulty: 3 people, 12.00%
Oedema (fluid collection in tissue): 3 people, 12.00%
Azotaemia (excess of urea or other nitrogenous compounds in the blood): 3 people, 12.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 12.00%
Prostate Cancer: 3 people, 12.00%
Anaemia (lack of blood): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Atrioventricular block complete?

Check whether Atrioventricular block complete is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Min IS, Lee JY, Jung TS, Kang NK, Park BB, Kim BK, "Development of a Complete Atrioventricular Block Associated with Intake of Evening Primrose Oil", The Korean Journal of Medicine, 2016 May .
Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .

Related studies

How severe was Atrioventricular block complete and when was it recovered:

Atrioventricular block complete in Ceftriaxone

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Atrioventricular block complete and drugs with ingredients of ceftriaxone sodium

Alternative drugs to, pros and cons of Ceftriaxone:

Ceftriaxone (33,567 reports)

Common Ceftriaxone side effects:

Fever: 2,393 reports
Drug ineffective: 1,874 reports
Pneumonia: 1,715 reports
Rashes (redness): 1,662 reports
Breathing difficulty: 1,364 reports
Diarrhea: 1,289 reports
Thrombocytopenia (decrease of platelets in blood): 1,275 reports
Hypotension (abnormally low blood pressure): 1,244 reports
Nausea and vomiting: 1,203 reports

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atrioventricular block complete treatments and more:

Atrioventricular block complete (8,312 reports)

COVID vaccines that are related to Atrioventricular block complete:

Common drugs associated with Atrioventricular block complete:

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.